APA

Schilling D., Spiethoff A., Rosenbaum A., Hartmann D., Eickhoff A., Jakobs R., Weickert U., Rebe M., Bohrer M. H. & Riemann J. F. (20050628). Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients. : Pathology, research and practice.

Chicago

Schilling D, Spiethoff A, Rosenbaum Anika, Hartmann D, Eickhoff A, Jakobs R, Weickert U, Rebe M, Bohrer M H and Riemann J F. 20050628. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients. : Pathology, research and practice.

Harvard

Schilling D., Spiethoff A., Rosenbaum A., Hartmann D., Eickhoff A., Jakobs R., Weickert U., Rebe M., Bohrer M. H. and Riemann J. F. (20050628). Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients. : Pathology, research and practice.

MLA

Schilling D, Spiethoff A, Rosenbaum Anika, Hartmann D, Eickhoff A, Jakobs R, Weickert U, Rebe M, Bohrer M H and Riemann J F. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients. : Pathology, research and practice. 20050628.